USPTO serial 90354073
XENTER
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- BECHHOFER, YOCHEVED D
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with XENTER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Salt Lake City, UT
Draper, UT
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
John C. Stringham
John C. Stringham WORKMAN NYDEGGER60 E. SOUTH TEMPLE, SUITE 1000SALT LAKE CITY, UT 84111United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable and recorded software for laboratory imaging; downloadable and recorded software for viewing, manipulating, querying, gathering, utilizing, storing and sharing images and data, obtaining medical information, and storing patient data for use in invasive vascular and structural interventions; downloadable and recorded software for hand-held laboratory imaging; downloadable and recorded software for viewing, manipulating, querying, gathering, utilizing, storing and sharing images and data, obtaining medical information, and storing patient data for use in cardiac care; downloadable and recorded software for imaging of cardiovascular and neurological systems; downloadable and recorded software for gathering, utilizing, storing, obtaining, viewing, manipulating, querying, analyzing, reporting and sharing medical images, physiological assessments, medical information and data; downloadable and recorded software for performing physiological assessments; downloadable and recorded software for performing medical assessments, namely, atherosclerotic lesion morphology and analytical predictive intraoperative histopathology; downloadable and recorded software for viewing, manipulating, querying, gathering, utilizing, storing and sharing images and data, obtaining medical information, and storing patient data for use in applied data and integrated solutions, namely, guidewires, catheters, and needles; downloadable and recorded software for viewing, manipulating, querying, gathering, utilizing, storing and sharing images and data, obtaining medical information, and storing patient data for use with physical intelligence medical devices; downloadable and recorded software for use in interventional, cardiovascular, and neurovascular procedures; downloadable and recorded software for viewing, manipulating, querying, gathering, utilizing, storing and sharing images and data, obtaining medical information, and storing patient data for use in esophagus, heart, and other organ procedures; downloadable and recorded software for viewing, manipulating, querying, gathering, utilizing, storing and sharing images and data, obtaining medical information, and storing patient data for use with procedures involving solid tumors; downloadable and recorded software for viewing, manipulating, querying, gathering, utilizing, storing and sharing images and data, obtaining medical information, and storing patient data for use with imaging software in interventional and cardiovascular procedures and related devices, namely, guidewires, catheters, and needles; downloadable and recorded software for use with gathering, analyzing and reporting hemodynamic information; downloadable and recorded software for identifying tip location of catheters and guidewires; physical intelligence downloadable and recorded software for viewing, manipulating, querying, gathering, utilizing, storing and sharing images and data, obtaining medical information, and storing patient data for use with intelligent guidewires, intelligent catheters, and intelligent needles; downloadable application software for laboratory imaging; downloadable application software for viewing, manipulating, querying, gathering, utilizing, storing and sharing images and data, obtaining medical information, and storing patient data for use in invasive vascular and structural interventions; downloadable application software for hand-held laboratory imaging; downloadable application software for viewing, manipulating, querying, gathering, utilizing, storing and sharing images and data, obtaining medical information, and storing patient data for cardiac care; downloadable application software for imaging of cardiovascular and neurological systems; downloadable application software for gathering, utilizing, storing, obtaining, viewing, manipulating, querying, analyzing, reporting and sharing medical images, physiological assessments, medical information and data; downloadable application software for performing physiological assessments; downloadable application software for performing medical assessments, namely, atherosclerotic lesion morphology and analytical predictive intraoperative histopathology; downloadable application software for viewing, manipulating, querying, gathering, utilizing, storing and sharing images and data, obtaining medical information, and storing patient data for use in applied data and integrated solutions, namely, guidewires, catheters, and needles; downloadable application software for viewing, manipulating, querying, gathering, utilizing, storing and sharing images and data, obtaining medical information, and storing patient data for use with physical intelligence medical devices; downloadable application software for viewing, manipulating, querying, gathering, utilizing, storing and sharing images and data, obtaining medical information, and storing patient data for use in interventional, cardiovascular, and neurovascular procedures; downloadable application software for viewing, manipulating, querying, gathering, utilizing, storing and sharing images and data, obtaining medical information, and storing patient data for use in esophagus, heart, and other organ procedures; downloadable application software for viewing, manipulating, querying, gathering, utilizing, storing and sharing images and data, obtaining medical information, and storing patient data for use with procedures involving solid tumors; downloadable application software for viewing, manipulating, querying, gathering, utilizing, storing and sharing images and data, obtaining medical information, and storing patient data for use with imaging software in interventional and cardiovascular procedures and related devices, guidewires, catheters, and needles; downloadable application software for use with gathering, analyzing and reporting hemodynamic information; downloadable application software for identifying tip location of catheters and guidewires; physical intelligence downloadable application software for viewing, manipulating, querying, gathering, utilizing, storing and sharing images and data, obtaining medical information, and storing patient data retrieved from intelligent guidewires, intelligent catheters, and intelligent needles | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 8, 2025 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 8, 2025 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 25, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 25, 2025 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Apr 25, 2025 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 29, 2025 | EXT5 | SOU EXTENSION 5 FILED | — |
| Jan 29, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 1, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 1, 2024 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Aug 1, 2024 | EXT4 | SOU EXTENSION 4 FILED | — |
| Aug 1, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 3, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 1, 2024 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Feb 1, 2024 | EXT3 | SOU EXTENSION 3 FILED | — |
| Feb 1, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 21, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 19, 2023 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jul 19, 2023 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jul 19, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 27, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 25, 2023 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 25, 2023 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 25, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 2, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 7, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 7, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 18, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 4, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 15, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 14, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 14, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 21, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 21, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 21, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 16, 2021 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Nov 9, 2021 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Oct 25, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 25, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 25, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 25, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 25, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 1, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 30, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 30, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 2, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 2, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 2, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 30, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 11, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 11, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 11, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 7, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 5, 2020 | NWAP | NEW APPLICATION ENTERED | — |